Research Use Only - Not for human consumption. 18+ only.
CGrade CPrimarily animal or in-vitro studies; limited human dataResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use onlyMuscle Growth & PerformanceSubcutaneous

Lysine-Arginine

A dipeptide combination that enhances nitric oxide production and vasodilation, improving blood flow and nutrient delivery to muscles.

Research Status

CGrade CPrimarily animal or in-vitro studies; limited human dataResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only

Research compound

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Enhances nitric oxide production
Improves blood flow and vasodilation
Supports muscle nutrient delivery
May improve exercise performance
Supports cardiovascular function

Side Effects

Gastrointestinal discomfort
UncommonMild

May occur with higher doses or in sensitive individuals. Typically resolves with dose reduction or taking with food. Nausea or mild stomach upset reported in some users.

Headache
UncommonMild

May be related to rapid vasodilation or changes in blood pressure. Usually mild and transient. Ensure adequate hydration.

Flushing or skin redness
UncommonMild

Related to vasodilation effects. Typically mild and temporary, resolving within minutes to hours.

Dizziness or lightheadedness
RareMild

May occur due to blood pressure changes from vasodilation. Sit or lie down if experienced. Ensure adequate hydration and electrolyte balance.

Local injection site reactions
UncommonMild

Mild redness, itching, or slight swelling at injection site. Typically resolves within hours. Rotate injection sites to minimize.

Allergic reaction
RareSerious

Seek immediate medical attention if experiencing rash, difficulty breathing, or swelling of face/throat. Discontinue use immediately.

Dosing Reference

ParameterValue
Dose range500-1000 mcg
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Lysine-Arginine is a dipeptide combination that works synergistically to enhance nitric oxide (NO) production in endothelial cells. Arginine serves as the substrate for nitric oxide synthase (NOS), the enzyme responsible for NO synthesis, while lysine may enhance arginine bioavailability and uptake. Increased nitric oxide promotes vasodilation, improves blood flow, and enhances nutrient and oxygen delivery to muscle tissue, potentially supporting exercise performance and recovery.

Pathways and mechanism detail available to members

Track your Lysine-Arginine research

Free account. No credit card required.

Start Free

Recent Research

All results

Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.

Research Citations

4 sources
  • Cormio L, De Siati M, Lorusso F, et al. (2011). Oral L-arginine supplementation improves in vitro fertilization outcome in male factor infertility: a prospective, randomized, placebo-controlled clinical trial. Fertil Steril. 96(6):1488-1493. PMID: 21993613

  • Stanislavov R, Nikolova V. (2003). Treatment of erectile dysfunction with pycnogenol and L-arginine. J Sex Marital Ther. 29(3):207-213. PMID: 12851125

  • Cormio L, De Siati M, Lorusso F, et al. (2011). Oral L-arginine supplementation improves in vitro fertilization outcome in male factor infertility. Fertil Steril. 96(6):1488-1493.

  • Böger RH. (2007). The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res. 73(2):290-297. PMID: 16973416

Browse the Research Library

133 peptide profiles and 54 blend profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Stay updated on Lysine-Arginine research

Weekly digest of new peptide research, stack guides, and platform updates.

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Lysine-Arginine is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.